393 related articles for article (PubMed ID: 36232835)
1. Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?
Sala-Jarque J; Zimkowska K; Ávila J; Ferrer I; Del Río JA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232835
[TBL] [Abstract][Full Text] [Related]
2. The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
Clavaguera F; Tolnay M; Goedert M
Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 27940600
[TBL] [Abstract][Full Text] [Related]
3. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
4. Tau Prion-Like Propagation: State of the Art and Current Challenges.
Dujardin S; Hyman BT
Adv Exp Med Biol; 2019; 1184():305-325. PubMed ID: 32096046
[TBL] [Abstract][Full Text] [Related]
5. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
[TBL] [Abstract][Full Text] [Related]
6. Prion-like Spreading in Tauopathies.
Ayers JI; Giasson BI; Borchelt DR
Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
[TBL] [Abstract][Full Text] [Related]
7. Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading.
Kundel F; Hong L; Falcon B; McEwan WA; Michaels TCT; Meisl G; Esteras N; Abramov AY; Knowles TJP; Goedert M; Klenerman D
ACS Chem Neurosci; 2018 Jun; 9(6):1276-1282. PubMed ID: 29590529
[TBL] [Abstract][Full Text] [Related]
8. What is the evidence that tau pathology spreads through prion-like propagation?
Mudher A; Colin M; Dujardin S; Medina M; Dewachter I; Alavi Naini SM; Mandelkow EM; Mandelkow E; Buée L; Goedert M; Brion JP
Acta Neuropathol Commun; 2017 Dec; 5(1):99. PubMed ID: 29258615
[TBL] [Abstract][Full Text] [Related]
9. Invited review: Prion-like transmission and spreading of tau pathology.
Clavaguera F; Hench J; Goedert M; Tolnay M
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):47-58. PubMed ID: 25399729
[TBL] [Abstract][Full Text] [Related]
10. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
11. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
Annadurai N; De Sanctis JB; Hajdúch M; Das V
Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
[TBL] [Abstract][Full Text] [Related]
12. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
Robert A; Schöll M; Vogels T
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200180
[TBL] [Abstract][Full Text] [Related]
13. Glial contributions to neurodegeneration in tauopathies.
Leyns CEG; Holtzman DM
Mol Neurodegener; 2017 Jun; 12(1):50. PubMed ID: 28662669
[TBL] [Abstract][Full Text] [Related]
14. Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.
Fuster-Matanzo A; Hernández F; Ávila J
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495325
[TBL] [Abstract][Full Text] [Related]
15. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.
Leroux E; Perbet R; Caillierez R; Richetin K; Lieger S; Espourteille J; Bouillet T; Bégard S; Danis C; Loyens A; Toni N; Déglon N; Deramecourt V; Schraen-Maschke S; Buée L; Colin M
Mol Ther; 2022 Feb; 30(2):782-797. PubMed ID: 34563677
[TBL] [Abstract][Full Text] [Related]
17. Trans-seeding of Alzheimer-related tau protein by a yeast prion.
Flach M; Leu C; Martinisi A; Skachokova Z; Frank S; Tolnay M; Stahlberg H; Winkler DT
Alzheimers Dement; 2022 Dec; 18(12):2481-2492. PubMed ID: 35142027
[TBL] [Abstract][Full Text] [Related]
18. Prion-like strain effects in tauopathies.
Han ZZ; Kang SG; Arce L; Westaway D
Cell Tissue Res; 2023 Apr; 392(1):179-199. PubMed ID: 35460367
[TBL] [Abstract][Full Text] [Related]
19. Proteopathic tau seeding predicts tauopathy in vivo.
Holmes BB; Furman JL; Mahan TE; Yamasaki TR; Mirbaha H; Eades WC; Belaygorod L; Cairns NJ; Holtzman DM; Diamond MI
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4376-85. PubMed ID: 25261551
[TBL] [Abstract][Full Text] [Related]
20. Bassoon contributes to tau-seed propagation and neurotoxicity.
Martinez P; Patel H; You Y; Jury N; Perkins A; Lee-Gosselin A; Taylor X; You Y; Viana Di Prisco G; Huang X; Dutta S; Wijeratne AB; Redding-Ochoa J; Shahid SS; Codocedo JF; Min S; Landreth GE; Mosley AL; Wu YC; McKinzie DL; Rochet JC; Zhang J; Atwood BK; Troncoso J; Lasagna-Reeves CA
Nat Neurosci; 2022 Dec; 25(12):1597-1607. PubMed ID: 36344699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
